Government subsidy on new drug development biased to Biotech.

The government subsidy on the new drug development inclined more to the biotech areas. The government subsidy programs have also suspended on the total 10 subjects since 2003.

The MOHW report presented to the National Assembly described that the government supported 18,329 million won for the R&D of new drugs on the total 41 subjects and 10,264 million won for the biotech drugs on the total...